Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Encompass Health Corp (EHC)

Encompass Health Corp (EHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,662,366
  • Shares Outstanding, K 99,416
  • Annual Sales, $ 5,935 M
  • Annual Income, $ 566,200 K
  • EBIT $ 1,381 M
  • EBITDA $ 1,719 M
  • 60-Month Beta 0.75
  • Price/Sales 1.81
  • Price/Cash Flow 12.19
  • Price/Book 3.39

Options Overview Details

View History
  • Implied Volatility 41.38% (+0.65%)
  • Historical Volatility 32.69%
  • IV Percentile 95%
  • IV Rank 6.54%
  • IV High 346.75% on 11/28/25
  • IV Low 20.00% on 09/11/25
  • Expected Move (DTE 5) 5.82 (5.43%)
  • Put/Call Vol Ratio 0.05
  • Today's Volume 534
  • Volume Avg (30-Day) 603
  • Put/Call OI Ratio 0.33
  • Today's Open Interest 7,504
  • Open Int (30-Day) 6,521
  • Expected Range 101.43 to 113.07

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $1.51
  • Number of Estimates 7
  • High Estimate $1.53
  • Low Estimate $1.48
  • Prior Year $1.37
  • Growth Rate Est. (year over year) +10.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
94.98 +12.92%
on 03/31/26
109.35 -1.92%
on 04/09/26
+0.36 (+0.34%)
since 03/10/26
3-Month
92.77 +15.61%
on 02/03/26
115.71 -7.31%
on 02/06/26
+4.32 (+4.20%)
since 01/09/26
52-Week
92.77 +15.61%
on 02/03/26
127.99 -16.20%
on 10/24/25
+5.12 (+5.01%)
since 04/10/25

Most Recent Stories

More News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Encompass Health Corporation - EHC

NEW YORK , April 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation ("Encompass" or the "Company") (NYSE: EHC).  Such investors...

EHC : 107.25 (-1.00%)
Encompass Health announces annual stockholder meeting date

BIRMINGHAM, Ala. , April 8, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) will hold its annual meeting of stockholders at 11 a.m. CT on Thursday, May 7, 2026. The meeting will be conducted...

EHC : 107.25 (-1.00%)
Encompass Health announces date of 2026 first-quarter earnings call

BIRMINGHAM, Ala. , April 7, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will report results for its first quarter ended March 31, 2026, after the market closes on Thursday,...

EHC : 107.25 (-1.00%)
2 Healthcare Stocks for Long-Term Investors and 1 We Ignore

2 Healthcare Stocks for Long-Term Investors and 1 We Ignore

EHC : 107.25 (-1.00%)
THC : 195.24 (-3.28%)
PFE : 26.92 (-1.10%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Encompass Health Corporation - EHC

NEW YORK , April 2, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation ("Encompass" or the "Company") (NYSE: EHC).  Such investors...

EHC : 107.25 (-1.00%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Encompass Health Corporation - EHC

NEW YORK , March 26, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation ("Encompass" or the "Company") (NYSE: EHC).  Such investors...

EHC : 107.25 (-1.00%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Encompass Health Corporation - EHC

NEW YORK , March 19, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation ("Encompass" or the "Company") (NYSE: EHC). Such investors...

EHC : 107.25 (-1.00%)
Encompass Health announces plans to build a 40-bed inpatient rehabilitation hospital in Bear, Delaware

BIRMINGHAM, Ala., and BEAR, Del. , March 18, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced plans to build a freestanding, 40-bed inpatient rehabilitation hospital in Bear,...

EHC : 107.25 (-1.00%)
2 Cash-Producing Stocks to Keep an Eye On and 1 We Question

2 Cash-Producing Stocks to Keep an Eye On and 1 We Question

NVMI : 496.06 (+0.40%)
EHC : 107.25 (-1.00%)
WDC : 343.43 (+1.64%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Encompass Health Corporation - EHC

NEW YORK , March 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation ("Encompass" or the "Company") (NYSE: EHC). Such investors are...

EHC : 107.25 (-1.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Encompass Health Corporation is a provider of integrated healthcare services. It offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The company delivers high-quality, cost-effective, integrated care...

See More

Key Turning Points

3rd Resistance Point 110.44
2nd Resistance Point 109.46
1st Resistance Point 108.35
Last Price 107.25
1st Support Level 106.27
2nd Support Level 105.29
3rd Support Level 104.18

See More

52-Week High 127.99
Fibonacci 61.8% 114.54
Fibonacci 50% 110.38
Last Price 107.25
Fibonacci 38.2% 106.22
52-Week Low 92.77

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.